Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial–mesenchymal transition (EMT) to mesenchymal–epithelial transition (MET) states

JOURNAL ARTICLE published March 2014 in British Journal of Cancer

Authors: T Yoshida | Y Ozawa | T Kimura | Y Sato | G Kuznetsov | S Xu | M Uesugi | S Agoulnik | N Taylor | Y Funahashi | J Matsui